Last reviewed · How we verify
Photodynamic Therapy
Photodynamic Therapy is a Small molecule drug developed by Roswell Park Cancer Institute. It is currently FDA-approved. Also known as: PDT, Photoradiation Therapy, Light Infusion Therapy™, therapy, photodynamic.
At a glance
| Generic name | Photodynamic Therapy |
|---|---|
| Also known as | PDT, Photoradiation Therapy, Light Infusion Therapy™, therapy, photodynamic, systemic chemotherapy |
| Sponsor | Roswell Park Cancer Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection (PHASE1, PHASE2)
- Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery (PHASE1)
- Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer (PHASE2)
- Phase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers: (PHASE2)
- Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP (NA)
- Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions (PHASE2)
- Photodynamic Treatment in the Management of Residual Biofilm - a Crossover Study (NA)
- Regular Home-use of Dual-light Photodynamic Therapy in the Management of Chronic Stage III-IV Periodontitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Photodynamic Therapy CI brief — competitive landscape report
- Photodynamic Therapy updates RSS · CI watch RSS
- Roswell Park Cancer Institute portfolio CI
Frequently asked questions about Photodynamic Therapy
What is Photodynamic Therapy?
Photodynamic Therapy is a Small molecule drug developed by Roswell Park Cancer Institute.
Who makes Photodynamic Therapy?
Photodynamic Therapy is developed and marketed by Roswell Park Cancer Institute (see full Roswell Park Cancer Institute pipeline at /company/roswell-park-cancer-institute).
Is Photodynamic Therapy also known as anything else?
Photodynamic Therapy is also known as PDT, Photoradiation Therapy, Light Infusion Therapy™, therapy, photodynamic, systemic chemotherapy.
What development phase is Photodynamic Therapy in?
Photodynamic Therapy is FDA-approved (marketed).
Related
- Manufacturer: Roswell Park Cancer Institute — full pipeline
- Also known as: PDT, Photoradiation Therapy, Light Infusion Therapy™, therapy, photodynamic, systemic chemotherapy
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing